Surgical and functional outcomes of Retzius-sparing robotic-assisted radical prostatectomy versus conventional robotic-assisted radical prostatectomy in patients with biopsy-confirmed prostate cancer. Are outcomes worth it? Systematic review and meta-analysis.
Mario A O'Connor-CordovaAlan Gabriel Ortega MacíasJuan Pablo Sancén-HerreraFrancisco AltamiranoAlexis Vargas Del ToroBharat Kumar PeddinaniPia Canal-ZarateMario A O'Connor-JuarezPublished in: The Prostate (2023)
Our analysis suggests that RS-RARP is safe and feasible. Faster continence recovery rate is seen after RS-RARP. Potency outcomes appear to be similar. PSM rates are not different following RS-RARP regardless of pathologic stage. Further quality studies are needed to confirm these findings.